Investors Reach $12M Deal In Biotech Stock-Drop Case

Law360 (November 13, 2018, 5:26 PM EST) -- A shareholder class claiming biotech company NantKwest hid millions of dollars in executive compensation expenses from investors prior to its 2015 initial public offering has reached a $12 million proposed settlement with the firm, according to a filing in California federal court.

The agreement was the result of seven depositions, 140,000 pages of documents and months of mediation that followed the initial March 22, 2016, filing of the case, according to court-appointed class plaintiffs Brayton Li and Donald Hu in their motion asking U.S. District Court Judge Michael Fitzgerald for preliminary approval Friday.

The class, which Judge Fitzgerald certified in August,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!